Factorial Optimization Trial to Test Effects of Coping Intervention Components
Launched by ARIZONA STATE UNIVERSITY · Apr 8, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain coping strategies can help children deal with anxiety and depression after their parents separate or divorce. The study focuses on three specific strategies: reappraisal (changing how you think about a situation), distraction (finding ways to take your mind off things), and relaxation (calming down). By testing these strategies, researchers hope to create a better program that can support children facing emotional challenges during this tough time.
To participate in this study, children aged 9 to 12 who have parents that are separated or divorced can apply, as long as they and one parent speak English and the parent is involved with the child. The study is looking for children who experience a lot of conflict between their parents and show some signs of emotional difficulties. Participants will engage in activities related to the coping strategies and will be asked to share their feelings and reactions to help researchers understand how these strategies can benefit them. It's important to know that children currently receiving therapy or those with severe emotional issues may not be eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • child between ages 9-12 whose parents are separated or divorced
- • child and one parent are fluent in English
- • a parent with sufficient contact (i.e., at least 4 overnights and/or 12 daytime visits per month) with child who is willing to complete study assessments and has legal right to give permission for the child to participate in research
- • child-report of high exposure to IPC (mean Z score ≥ 40th percentile on the two child report measures of IPC; score standardization based on data from 559 youth whose parents participated in an experimental parenting program)
- • elevated internalizing or externalizing problems (T score in the borderline clinical range according to either child or parent report on the BPM).
- Exclusion Criteria:
- • in active therapy
- • score ≥ 99th percentile on either internalizing and externalizing problems subscale
- • endorse suicidality (will be ineligible for the study and referred for treatment)
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tempe, Arizona, United States
Patients applied
Trial Officials
Karey L O'Hara, PhD
Principal Investigator
Arizona State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported